Results 281 to 290 of about 191,621 (404)
No Association Between Proton Pump Inhibitor Use and Risk of Alzheimer’s Disease
H. Taipale +5 more
semanticscholar +1 more source
PCN‐Rh single‐atom catalyst shows a dual‐cycle reaction path for photocatalytic hydrogen evolution (PHE). PCN‐Rh‐0.5 achieves 32.5 times the PHE rate of PCN/Pt, which exhibits a longer operation time (192 h) with a higher amount of hydrogen production (654.5 mmol g−1) than the reported PCN‐based single‐atom catalysts and other high‐stability catalysts ...
Chunmei Li +8 more
wiley +1 more source
Sporadic Fundic Gland Polyposis Associated With Long-Term Proton Pump Inhibitor Use: A Case Report. [PDF]
Li H, Tey TT.
europepmc +1 more source
Advanced Therapeutic Approach Based on LDHs–Mimetic Oxidoreductase
Overview of Sructure, Multienzyme‐mimicking Activity and Advanced Therapeutic Approach Based on LDHs–Mimetic Oxidoreductase. Abstract Redox dysregulation is recognized as a key driver in the pathophysiology of numerous refractory diseases, contributing significantly to the progression and poor prognosis.
Kai Song +9 more
wiley +1 more source
Proton pump inhibitor exposure, trabecular bone score, and BMD: a registry-based cohort study. [PDF]
Zarzour F +4 more
europepmc +1 more source
Acinetobacter regulates dinotefuran tolerance in Propylea japonica by mediating the expression of the horizontally transferred gene PjDUF1. Abstract Insect–microbial symbiont relationships are widespread in nature and often involve lateral gene transfer.
Ningbo HuangFu +10 more
wiley +1 more source

